STAT : Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent
Catalent was cited by the FDA for quality control failures at a facility in Bloomington, Ind., where the company helps produce two Covid-19 vaccines.
STAT : Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent
Catalent was cited by the FDA for quality control failures at a facility in Bloomington, Ind., where the company helps produce two Covid-19 vaccines.